The stock price of Elanco, a pharmaceuticals company focused on medicines for pets and livestock, has seen a large 19% fall over the last five trading days, and much of this fall has come in yesterday's trading session (Aug 9), following the company's Q2 release. While the company reported upbeat...
The stock price of Elanco, a pharmaceuticals company focused on medicines for pets and livestock, has seen a large 19% fall over the last five trading days, and much of this fall has come in yesterday's trading session (Aug 9), following the company's Q2 release. While the company reported upbeat...
Share this Article
Recommended